Use of BCG as an immunostimulant after resection of carcinoma of the lung: a two-year assessment of a trial of 500 patients.
BCG (Glaxo) (0.5 ml = 5 X 10(6) organisms) was given subdermally to 250 patients ten days after resection of a lung carcinoma to stimulate the immune system. Increased activity of lymphocytes and macrophages could possibly result in the destruction of small extrapulmonary tumour deposits that were p...
Bewaard in:
| Gepubliceerd in: | Thorax |
|---|---|
| Hoofdauteur: | |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BMJ Publishing Group
1979
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC471200/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/396688/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/thx.34.6.801 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|